Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription

Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 32 articles:
HTML format

Single Articles

    November 2021
  1. MOREIRA JLS, Barbosa SMB, Goncalves Junior J
    Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review.
    Clin Res Hepatol Gastroenterol. 2021;45:101752.
    PubMed     Abstract available

    September 2021
  2. CHAIBI S, Boussier J, Hajj WE, Abitbol Y, et al
    Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort.
    Clin Res Hepatol Gastroenterol. 2021;45:101556.
    PubMed     Abstract available

    July 2021
  3. LANTHIER N, Starkel P, Dahlqvist G
    Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?
    Clin Res Hepatol Gastroenterol. 2021;45:101721.
    PubMed     Abstract available

    June 2021
  4. RAZAQ S, Kara M, Ozcakar L
    Measure Grip Strength, Gait Speed and Quadriceps Muscle in Cirrhosis. Comment to "Frailty, sarcopenia and mortality in cirrhosis: What is the best assessment, how to interpret the data correctly and what interventions are possible?"
    Clin Res Hepatol Gastroenterol. 2021 Jun 1:101727.

    May 2021
  5. VUJAKLIJA BRAJKOVIC A, Zlopasa O, Gubarev Vrdoljak N, Goran T, et al
    Acute liver and cardiac failure in multisystem inflammatory syndrome in adults after COVID-19.
    Clin Res Hepatol Gastroenterol. 2021;45:101678.

  6. SERRA F, Bonaduce I, De Ruvo N, Cautero N, et al
    Covid-19 and hepatic injury: A systematic review.
    Clin Res Hepatol Gastroenterol. 2021;45:101605.

  7. SHIHA G, Soliman R, Mikhail N, Zaky S, et al
    HCC developed in CHC patients who achieved SVR following DAAs tend to display less aggressive pattern.
    Clin Res Hepatol Gastroenterol. 2021;45:101608.

    April 2021
    Prognostic value of gamma-glutamyl transpeptidase in liver cirrhosis and hepatocellular cancer regardless of other parameters.
    Clin Res Hepatol Gastroenterol. 2021 Apr 27:101708.

    November 2020
  9. BEST MG, Wurdinger T
    Tumor-educated platelets for the earlier detection of hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2020;44:794-795.

    October 2020
  10. WANG H, Qiu P, Liu J, Wang F, et al
    The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2020;44:653-661.
    PubMed     Abstract available

  11. RAHAL HK, Tabibian JH
    The MBOAT7 rs641738 variant in primary sclerosing cholangitis: A novel biomarker for prognostication.
    Clin Res Hepatol Gastroenterol. 2020;44:619-621.

    September 2020
  12. ALI N
    Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?
    Clin Res Hepatol Gastroenterol. 2020;44:e84-e86.

    August 2020
  13. ELKRIEF L, Houssel-Debry P, Ackermann O, Franchi-Abella S, et al
    Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.
    Clin Res Hepatol Gastroenterol. 2020 Aug 17. pii: S2210-7401(20)30091.
    PubMed     Abstract available

    June 2020
  14. DE GOTTARDI A, Fratila C, Bertoli R, Cerny A, et al
    Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection.
    Clin Res Hepatol Gastroenterol. 2020 Jun 10. pii: S2210-7401(20)30159.
    PubMed     Abstract available

  15. GANNE-CARRIE N, Fontaine H, Dumortier J, Boursier J, et al
    Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic.
    Clin Res Hepatol Gastroenterol. 2020;44:275-281.
    PubMed     Abstract available

    April 2020
  16. ABERGEL A, Gasperment M, Nery FG, Buchard B, et al
    Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.
    Clin Res Hepatol Gastroenterol. 2020 Apr 17. pii: S2210-7401(20)30089.

    March 2020
  17. FELLI E, Baumert T, Pessaux P
    Is minimally invasive true anatomical HCC resection a future way to improve results in bridge or salvage liver transplantation?
    Clin Res Hepatol Gastroenterol. 2020 Mar 18. pii: S2210-7401(20)30049.

  18. MORANDEAU E, Rayer C, Jezequel C, Guyader D, et al
    Hepatic encephalopathy post liver transplantation.
    Clin Res Hepatol Gastroenterol. 2020 Mar 10. pii: S2210-7401(20)30039.

    January 2020
  19. PETA V, Zhu J, Lubman DM, Huguet S, et al
    Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
    Clin Res Hepatol Gastroenterol. 2020 Jan 18. pii: S2210-7401(19)30272.
    PubMed     Abstract available

  20. HEDJOUDJE A, Cervoni JP, Patry C, Chatot M, et al
    Takotsubo cardiomyopathy triggered by delirium tremens in a cirrhotic patient with acute-on-chronic liver failure: A case report.
    Clin Res Hepatol Gastroenterol. 2020 Jan 9. pii: S2210-7401(19)30262.
    PubMed     Abstract available

    December 2019
  21. GOUMARD C, Scatton O
    Resectable HCC: Should salvage liver transplantation for HCC be discussed de principe?
    Clin Res Hepatol Gastroenterol. 2019 Dec 18. pii: S2210-7401(19)30251.

    November 2019
  22. ALLAIRE M, Cadranel JF, Nguyen TTN, Garioud A, et al
    Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.
    Clin Res Hepatol Gastroenterol. 2019 Nov 6. pii: S2210-7401(19)30224.
    PubMed     Abstract available

    October 2019
  23. ALLAIRE M, Walter A, Sutter O, Nahon P, et al
    TIPS for management of portal-hypertension-related complications in patients with cirrhosis.
    Clin Res Hepatol Gastroenterol. 2019 Oct 26. pii: S2210-7401(19)30217.
    PubMed     Abstract available

    August 2019
    Quantitative SHG-microscopy: Unraveling the nano-architecture of the cirrhotic liver.
    Clin Res Hepatol Gastroenterol. 2019 Aug 12. pii: S2210-7401(19)30174.

    June 2019
  25. LIBERAL R, Gaspar R, Lopes S, Macedo G, et al
    Primary biliary cholangitis in patients with inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2019 Jun 3. pii: S2210-7401(19)30099.
    PubMed     Abstract available

    April 2019
  26. SCHIELKE A, Scatton O, Boelle PY, Perdigao F, et al
    Ischemic-type biliary lesions: A leading indication of liver retransplantation with excellent results.
    Clin Res Hepatol Gastroenterol. 2019;43:131-139.
    PubMed     Abstract available

  27. MURATORI P, Lenzi M, Muratori L
    Diagnosis of primary biliary cholangitis in a "teen" male patient.
    Clin Res Hepatol Gastroenterol. 2019;43:e20-e21.

    March 2019
  28. YANG F, Ren H, Gao Y, Zhu Y, et al
    The value of severe vitamin D deficiency in predicting the mortality risk of patients with liver cirrhosis: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2019 Mar 29. pii: S2210-7401(19)30052.
    PubMed     Abstract available

  29. MAESTAS C, Lazkani M, Sultan M, Kolli G, et al
    Severe takotsubo cardiomyopathy following orthotopic liver transplantation: A case series.
    Clin Res Hepatol Gastroenterol. 2019 Mar 7. pii: S2210-7401(18)30266.
    PubMed     Abstract available

  30. QU W, Zhu ZJ, Wei L, Sun LY, et al
    Feasibility of domino liver transplantation from hyperhomocsyteinemia.
    Clin Res Hepatol Gastroenterol. 2019 Mar 7. pii: S2210-7401(19)30039.
    PubMed     Abstract available

    January 2019
  31. LEBRAY P, Varnous S
    Combined heart and liver transplantation: State of knowledge and outlooks.
    Clin Res Hepatol Gastroenterol. 2019 Jan 8. pii: S2210-7401(18)30173.
    PubMed     Abstract available

    December 2018
  32. BERGERE M, Erard-Poinsot D, Boillot O, Valette PJ, et al
    Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Clin Res Hepatol Gastroenterol. 2018 Dec 18. pii: S2210-7401(18)30268.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.